{"filing":{"accession_number":"0001628280-26-039293","cik":"0000910329","ticker":"MED","company_name":"MEDIFAST INC","form":"8-K","filing_date":"2026-06-01","report_date":null,"primary_document":"med-20260529.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/910329/000162828026039293/med-20260529.htm"},"events":[{"id":2608,"run_id":2262,"accession_number":"0001628280-26-039293","anchor_item_number":"5.02","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.92,"summary":"Jason L. Groves, the Chief Legal Officer \u0026 Corporate Secretary, tendered his resignation effective May 29, 2026. While the disclosure includes severance terms (one month base salary), the principal disclosed action is the departure of a named executive officer from a material role. The filing explicitly states the departure was not due to disagreement or operational issues, and the company is conducting a search for a permanent replacement, confirming this is a straightforward executive departure rather than a compensation arrangement or appointment.","company_name":"MEDIFAST INC","ticker":"MED","filing_date":"2026-06-01","items":[{"id":3342,"accession_number":"0001628280-26-039293","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"Jason L. Groves, the Chief Legal Officer \u0026 Corporate Secretary, tendered his resignation effective May 29, 2026. While the disclosure includes severance terms (one month base salary), the principal disclosed action is the departure of a named executive officer from a material role. The filing explicitly states the departure was not due to disagreement or operational issues, and the company is conducting a search for a permanent replacement, confirming this is a straightforward executive departure rather than a compensation arrangement or appointment.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-02T03:07:52.950559+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":3342,"accession_number":"0001628280-26-039293","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"Jason L. Groves, the Chief Legal Officer \u0026 Corporate Secretary, tendered his resignation effective May 29, 2026. While the disclosure includes severance terms (one month base salary), the principal disclosed action is the departure of a named executive officer from a material role. The filing explicitly states the departure was not due to disagreement or operational issues, and the company is conducting a search for a permanent replacement, confirming this is a straightforward executive departure rather than a compensation arrangement or appointment.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-02T03:07:52.950559+00:00","company_name":"MEDIFAST INC","ticker":"MED","filing_date":"2026-06-01"}]}